Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 8th July 2024
In the ordinary rebalance, the following composition will be implemented effective open 08.07.2024:
ABBOTT LABORATORIES |
ABBVIE INC |
ALCON INC |
AMEDISYS INC |
BAXTER INTL. |
BECTON DICKINSON AND CO |
BIOMERIEUX |
BOSTON SCIENTIFIC CORP |
BRISTOL-MYERS SQUIBB CO |
CENTENE CORP |
CEREVEL THERAPEUTICS HOLDINGS INC |
DANAHER CORP |
DENTSPLY SIRONA INC |
ELEVANCE HEALTH INC |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
ESSILORLUXOTTICA |
FRESENIUS SE & CO KGAA |
GALDERMA GROUP AG |
GSK PLC |
HOLOGIC INC |
INCYTE CORP |
JOHNSON & JOHNSON |
LABCORP HOLDINGS INC |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERCK KGAA |
MERIT MEDICAL SYSTEMS INC |
MOLINA HEALTHCARE INC |
NOVARTIS AG |
OPTION CARE HEALTH INC |
PFIZER INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
RECORDATI SPA |
REGENERON PHARMACEUTICALS |
REVVITY INC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SANOFI SA |
SIEMENS HEALTHINEERS AG |
SONOVA HOLDING AG |
STERIS PLC |
STRYKER CORP |
THE CIGNA GROUP |
THERMO FISHER SCIENTIFIC INC |
UCB SA |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |
ZIMMER BIOMET HOLDINGS INC |